S&P ASX All Technology

US Dollar vs AUD

Level up your trading with our powerful tools and real-time insights all in one place.

Get Started

RVNC Revance Therapeutics Inc

3.68

-0.01 (-0.27%)

Last Updated: 04:44:40

Delayed by 15 minutes

Confidential Treatment Order (ct Order)

This regulatory filing also includes additional resources:
filename1.pdf

Revance Therapeutics (NASDAQ:RVNC)
Historical Stock Chart
From Mar 2024 to May 2024

Click Here for more Revance Therapeutics Charts.

Revance Therapeutics (NASDAQ:RVNC)
Historical Stock Chart
From May 2023 to May 2024

Click Here for more Revance Therapeutics Charts.

Revance Therapeutics, Inc. News

Revance to Present New DAXXIFY® Data at the American Academy of Neurology 2024 Annual Meeting
Friday 12 April 2024 (3 weeks ago) • Business Wire

Revance Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Thursday 28 March 2024 (1 month ago) • Business Wire

Form 4 - Statement of changes in beneficial ownership of securities
Saturday 9 March 2024 (2 months ago) • Edgar (US Regulatory)

Form 8-K - Current report
Wednesday 6 March 2024 (2 months ago) • Edgar (US Regulatory)

Form 424B5 - Prospectus [Rule 424(b)(5)]
Wednesday 6 March 2024 (2 months ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Tuesday 5 March 2024 (2 months ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Tuesday 5 March 2024 (2 months ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Tuesday 5 March 2024 (2 months ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Tuesday 5 March 2024 (2 months ago) • Edgar (US Regulatory)

Revance Announces Pricing of $100.0 Million Public Offering of Common Stock
Tuesday 5 March 2024 (2 months ago) • Business Wire

Form 424B5 - Prospectus [Rule 424(b)(5)]
Monday 4 March 2024 (2 months ago) • Edgar (US Regulatory)

Revance Announces Proposed Public Offering of Common Stock
Monday 4 March 2024 (2 months ago) • Business Wire

More Revance Therapeutics, Inc. News Articles

Commonwealth Bank Of Aus...

Australian SE All Ordina...

Newcrest Mining

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions